ESC Professional Premium Access

Insights into arrhythmia mechanisms

Event: ESC Congress 2022
Topic: Arrhythmias, General
Session type: Advances in Science
Date: 26 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

State-of-the-art lecture in arrhythmia mechanisms.

Speaker: Professor U. Schotten (Maastricht, NL)

Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Speaker: Miss A. Paasche (Heidelberg, DE)

Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model

Speaker: Professor G. Frommeyer (Munster, DE)

3 speakers from this session

Professor Ulrich Schotten

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
3 presentations
0 follower

Miss Amelie Paasche

, Heidelberg (Germany)
0 follower

Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)
0 follower

This platform is supported by

logo Novo Nordisk